fda tirzepatide shortage resolved october 2 2024 π¨ Alert: No Longer on FDA's Drug List As of 2, 2024, the has announced that the Tirzepatide shortage has been resolved. This means that all doses of Mounjaro will remain off shortage
Description
Long-term outlook and what the research shows Retatrutide is still in clinical development, with Phase 3 trials ongoing
OTC pain relievers for discomfort When injection site reactions cause pain, tenderness, or significant discomfort, over-the-counter pain relievers provide additional relief
This content is not medical advice, does not replace consultation with a licensed healthcare professional, and does not guarantee eligibility for any prescription treatment
For brand-name tirzepatide, no
Simonetti recommends checking the FDA's list of registered compounding pharmacies
